Part B - Surviving Blood Loss: First in Human Studies to Assess Safety and Physiological Effects of Synthetic Ethinyl Estradiol-3-Sulfate (EE·3·SO4) in Healthy Subjects, Both Euvolemic and Following 10-20% Iatrogenic Blood Loss

Grant

Awarded By

Total Award Amount

  • 1737715.00

    • Direct Costs

  • 1188345.00

    • Sponsor Award Id

  • W911QY-15-C-0134

    • Contributor

  • Irshad Chaudry   Principal Investigator